NEK7 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.436800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.494200E-01
Normal-vs-Stage2
5.627400E-01
Normal-vs-Stage3
9.017600E-01
Normal-vs-Stage4
4.930200E-01
Stage1-vs-Stage2
4.540600E-01
Stage1-vs-Stage3
8.494200E-01
Stage1-vs-Stage4
4.589400E-01
Stage2-vs-Stage3
4.344600E-01
Stage2-vs-Stage4
9.026400E-01
Stage3-vs-Stage4
4.504600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.807600E-01
Normal-vs-AfricanAmerican
2.981800E-01
Normal-vs-Asian
8.235800E-01
Caucasian-vs-AfricanAmerican
5.079600E-01
Caucasian-vs-Asian
7.665400E-01
AfricanAmerican-vs-Asian
4.663600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.425200E-01
Normal-vs-Female
6.289000E-01
Male-vs-Female
7.981000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.168200E-01
Normal-vs-Age(41-60Yrs)
4.239400E-01
Normal-vs-Age(61-80Yrs)
7.389000E-01
Normal-vs-Age(81-100Yrs)
7.195000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.086400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.217600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.901600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.725600E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.093410E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.144600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.633600E-01
Normal-vs-Daily Drinker
9.578000E-01
Normal-vs-Weekly Drinker
8.678600E-01
Normal-vs-Occasional Drinker
3.775600E-01
Normal-vs-Social Drinker
6.971800E-01
Non Drinker-vs-Daily Drinker
4.931200E-01
Non Drinker-vs-Weekly Drinker
8.807600E-01
Non Drinker-vs-Occasional Drinker
9.890400E-02
Non Drinker-vs-Social Drinker
5.955800E-01
Daily Drinker-vs-Weekly Drinker
7.021800E-01
Daily Drinker-vs-Occasional Drinker
4.327600E-02
Daily Drinker-vs-Social Drinker
3.894600E-01
Weekly Drinker-vs-Occasional Drinker
1.417200E-01
Weekly Drinker-vs-Social Drinker
5.793200E-01
Occasional Drinker-vs-Social Drinker
4.519400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.061640E-01
Normal-vs-Grade 2
2.399500E-02
Normal-vs-Grade 3
2.946300E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.964200E-02
Grade 1-vs-Grade 3
7.344600E-03
Grade 1-vs-Grade 4
1.061640E-01
Grade 2-vs-Grade 3
1.944840E-01
Grade 2-vs-Grade 4
2.399500E-02
Grade 3-vs-Grade 4
2.946300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.331200E-01
Normal-vs-NonDiabetic
6.771200E-01
Diabetic-vs-NonDiabetic
5.201200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.912000E-01
Normal-vs-NoPancreatitis
6.758400E-01
Pancreatitis-vs-NoPancreatitis
1.874560E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.311200E-01
Normal-vs-N1
5.893800E-01
N0-vs-N1
8.130800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.441670E-02
Normal-vs-TP53-NonMutant
9.621000E-01
TP53-Mutant-vs-TP53-NonMutant
9.770300E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
